Exenatide once weekly: clinical outcomes and patient satisfaction.
about
Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetesOverview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.
P2860
Exenatide once weekly: clinical outcomes and patient satisfaction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Exenatide once weekly: clinical outcomes and patient satisfaction.
@ast
Exenatide once weekly: clinical outcomes and patient satisfaction.
@en
Exenatide once weekly: clinical outcomes and patient satisfaction.
@nl
type
label
Exenatide once weekly: clinical outcomes and patient satisfaction.
@ast
Exenatide once weekly: clinical outcomes and patient satisfaction.
@en
Exenatide once weekly: clinical outcomes and patient satisfaction.
@nl
prefLabel
Exenatide once weekly: clinical outcomes and patient satisfaction.
@ast
Exenatide once weekly: clinical outcomes and patient satisfaction.
@en
Exenatide once weekly: clinical outcomes and patient satisfaction.
@nl
P2860
P356
P1476
Exenatide once weekly: clinical outcomes and patient satisfaction
@en
P2093
Anthony H Barnett
Milan K Piya
P2860
P304
P356
10.2147/PPA.S7494
P407
P577
2010-09-07T00:00:00Z